Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians

Table 1 Ongoing clinical trials about locoregional treatments in locally advanced pancreatic cancer

Combination	Inclusion criteria	Start	Clinical trial identifier1	Expected end of accrual
FOLFIRINOX + SBRT	T ≤ 7 cm, non-metastatic	November 14	NCT02292745	November 20
RFA	Unresectable, also metastatic	June 14	NCT02166190	June 16
Cryoablation	Borderline resectable/locally advanced	November 14	NCT02336672	November 16
Radioembolization	unresectable/failure of celiac alcholization	Not available	NCT01786850	Not available
Irreversible electroporation (PAN.FIRE)	T < 5 cm, non-metastatic	September 13	NCT01939665	June 16

RFA: Radiofrequency ablation; SBRT: Stereotactic body radiation therapy;

¹Data Available from: URL: http// http://www.clinicaltrials.gov (last access 2015 May 24).